NPI: 1568659233 · EL CAJON, CA 92020 · Professional Counselor · NPI assigned 09/26/2007
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 09/26/2007 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,725 | $71K |
| 2019 | 1,436 | $59K |
| 2020 | 20,340 | $219K |
| 2021 | 55,826 | $833K |
| 2022 | 39,748 | $510K |
| 2023 | 7,686 | $150K |
| 2024 | 870 | $39K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 78,574 | 72,598 | $649K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 12,591 | 11,502 | $393K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 19,187 | 17,994 | $262K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3,207 | 3,204 | $169K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,679 | 2,538 | $127K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2,568 | 2,547 | $114K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,143 | 1,956 | $73K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,393 | 1,314 | $70K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 617 | 610 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 947 | 937 | $4K |
| 99201 | 93 | 93 | $3K | |
| 90715 | 59 | 59 | $2K | |
| 90674 | 95 | 95 | $2K | |
| 86580 | 610 | 593 | $2K | |
| 0064A | 41 | 41 | $2K | |
| 90686 | 53 | 53 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12 | 12 | $610.59 |
| 81002 | 218 | 209 | $434.10 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 52 | 50 | $405.03 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 56 | 28 | $35.40 |
| 1036F | 901 | 832 | $12.00 | |
| 3074F | 140 | 136 | $0.00 | |
| 3008F | 621 | 593 | $0.00 | |
| 3079F | 16 | 16 | $0.00 | |
| 1160F | 357 | 342 | $0.00 | |
| 1159F | 321 | 308 | $0.00 | |
| 3078F | 80 | 79 | $0.00 |